INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 179 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $689 | -3.9% | 10,057 | -2.9% | 0.00% | 0.0% |
| Q1 2024 | $717 | -3.4% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $742 | -31.3% | 10,361 | -50.0% | 0.00% | 0.0% |
| Q3 2023 | $1,080 | +64.6% | 20,722 | +100.0% | 0.00% | 0.0% |
| Q2 2023 | $656 | +16.9% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $561 | +2.4% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $548 | -99.9% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $482,000 | -18.4% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $591,000 | -6.8% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $634,000 | +17.0% | 10,361 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $542,000 | +40.4% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $386,000 | -8.7% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $423,000 | +20.2% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $352,000 | +7.0% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $329,000 | +23.7% | 10,361 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $266,000 | 0.0% | 10,361 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $266,000 | +67.3% | 10,361 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $159,000 | -18.5% | 10,361 | +82.2% | 0.00% | 0.0% |
| Q4 2019 | $195,000 | +364.3% | 5,687 | 0.0% | 0.00% | – |
| Q3 2019 | $42,000 | -43.2% | 5,687 | 0.0% | 0.00% | – |
| Q2 2019 | $74,000 | +7.2% | 5,687 | 0.0% | 0.00% | – |
| Q1 2019 | $69,000 | +6.2% | 5,687 | 0.0% | 0.00% | – |
| Q4 2018 | $65,000 | -47.2% | 5,687 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $123,000 | +179.5% | 5,687 | +127.8% | 0.00% | – |
| Q2 2018 | $44,000 | -17.0% | 2,497 | 0.0% | 0.00% | – |
| Q1 2018 | $53,000 | +47.2% | 2,497 | 0.0% | 0.00% | – |
| Q4 2017 | $36,000 | – | 2,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 375,000 | $15,308,000 | 5.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 113,258 | $4,623,000 | 2.06% |
| Tri Locum Partners LP | 150,783 | $6,155,000 | 2.02% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $2,495,000 | 1.64% |
| Vantage Consulting Group Inc | 226,670 | $9,252,000 | 1.61% |
| Nicholas Investment Partners, LP | 598,261 | $24,421,000 | 1.53% |
| Bellevue Group AG | 3,609,919 | $147,357,000 | 1.44% |
| GENERAL AMERICAN INVESTORS CO INC | 350,804 | $14,320,000 | 1.20% |
| Rhenman & Partners Asset Management AB | 429,728 | $17,541,000 | 1.19% |
| WASATCH ADVISORS LP | 6,506,789 | $265,607,000 | 1.08% |